Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-69.34	107.25	-349.79
Graham Fair Price	41.42	5.66	4.00
PEG	275.04	-0.04	0.01
Price/Book	-6.45	0.06	0.07
Price/Cash Flow	69.61	-2.89	-9.50
Prices/Earnings	53.23	-3.75	-8.03
Price/Sales	-53.23	1.34	2.87
Price/FCF	69.61	-2.89	-9.50
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-0.67	0.63	0.64
Operating Margin	-4.12	-0.12	-0.12
ROA	-100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-100.00
ROIC	< 0.005	< 0.005	-99.10
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.03	-0.10	-74.37
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.59	-1.08	83.42
EPS QOQ	-8.02	-1.00	87.53
FCF QOQ	-0.50	-2.08	-313.07
Revenue QOQ	-0.45	1.00	122.88
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	130.84	64.66	-50.58
Days Sales Outstanding (DSO)	70.03	13.72	-80.41
Inventory Turnover	0.69	1.39	102.34
Debt/Capitalization	0.16	0.16	-3.79
Quick Ratio	1.18	1.05	-10.92
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	18.40	18.40	< 0.005
Cash	1.54	1.54	< 0.005
Capex	-0.03	-0.06	-100.00
Free Cash Flow	-0.13	-0.40	-207.79
Revenue	0.43	0.87	100.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.32	1.32	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-238.59	75.47	-68.37
Naive Interpretation	Member

06 - Financial Health · Weak

Rating